Perrigo Company plc ($PRGO) Stock Forecast: Down 5.0% Today

What is Perrigo Company plc?

Perrigo Company plc (PRGO) is a global healthcare supplier that develops, manufactures, and distributes over-the-counter (OTC) consumer goods and pharmaceutical products. The company focuses on providing affordable healthcare solutions to consumers worldwide.

Why is Perrigo Company plc going down?

PRGO stock is down 5.0% on May 11, 2026 19:55

• Perrigo Company plc (PRGO) experienced a strong bearish movement today, closing down 4.40% at $11.72.
• Despite beating earnings estimates with an adjusted EPS of $0.43 per share in Q1, Perrigo's revenue of $969.2 million fell short of expectations, contributing to the stock's decline.
• The challenging market conditions, retailer inventory destocking, and revenue miss likely weighed on investor sentiment, leading to the bearish movement in the stock.
• Vanguard Group Inc.'s increased stake in the company may indicate long-term confidence, but short-term market factors and revenue concerns seem to have driven the stock price down today.

PRGO Price Chart

PRGO Technical Analysis

PRGO News

Vanguard Group Inc. Buys 1,101,154 Shares of Perrigo Company plc $PRGO

Vanguard Group Inc. increased its stake in Perrigo Company plc by 7.9% in the fourth quarter, acquiring an additional 1.1 million shares. This brings their total holding to 14.98 million shares, representing about 10.89% of the company. Despite Perrigo reporting Q1 earnings of $0.43 per share that beat estimates, its revenue of $841.8 million fell short and declined 7.2% year over year. The company declared a quarterly dividend of $0.29 per share, resulting in an annualized yield of around 9.9%, while analysts generally hold a "Hold" rating for the stock with a $19.33 target price.

https://www.marketbeat.com/instant-alerts/filing-vanguard-group-inc-buys-1101154-shares-of-perrigo-company-plc-prgo-2026-05-10/

Perrigo Company plc Q1 2026 Earnings Call Summary

Perrigo Company plc reported an 8.3% CORE net sales decline in Q1 2026, primarily due to a challenging market and retailer inventory destocking, but reaffirmed its full-year guidance expecting a strong second-half recovery. The company's 'Three-S' plan has improved U.S. store brand OTC volume share, and strategic initiatives like the Dermacosmetics divestiture and ongoing reviews of Infant Formula and Oral Care aim to streamline its portfolio and reduce debt. Innovation, particularly in nicotine replacement therapy and new Infant Formula offerings, is expected to be the main growth driver in the latter half of the year.

https://finance.yahoo.com/sectors/healthcare/articles/perrigo-company-plc-q1-2026-123000740.html

Perrigo Co. PLC stock underperforms Thursday when compared to competitors

Perrigo Co. PLC (PRGO) stock fell 4.40% on Thursday, closing at $11.72. This underperformance occurred on a generally poor day for the stock market, with both the S&P 500 and Dow Jones Industrial Average also declining. The stock's fall ended a two-day winning streak.

https://www.marketwatch.com/data-news/perrigo-co-plc-stock-underperforms-thursday-when-compared-to-competitors-f40e2f9e-f4e4765c9714?mod=mw_quote_news

Earnings Flash (PRGO) Perrigo Company Plc Reports Q1 Revenue $969.2M, Vs. FactSet Est of $1.04B

Perrigo Company Plc (PRGO) announced its Q1 revenue was $969.2 million, falling short of FactSet's estimate of $1.04 billion. This summary highlights the key financial outcome for the company's first quarter.

https://www.moomoo.com/news/post/69461256/earnings-flash-prgo-perrigo-company-plc-reports-q1-revenue-969?futusource=news_newspage_recommend

Earnings Flash (PRGO) Perrigo Company Plc Posts Q1 Adjusted EPS $0.43 per Share, Vs. FactSet Est of $0.31

Perrigo Company Plc (PRGO) reported strong first-quarter adjusted EPS of $0.43 per share, significantly surpassing the FactSet estimate of $0.31 per share. This financial performance indicates a better-than-expected quarter for the company.

https://www.moomoo.com/news/post/69461201/earnings-flash-prgo-perrigo-company-plc-posts-q1-adjusted-eps?futusource=news_newspage_recommend

Trending Today

Perrigo Company plc ($PRGO) Stock Forecast: Down 5.0% Today

CF Industries Holdings Inc. ($CF) Stock Forecast: Up 5.6% Today

Airbnb Inc. ($ABNB) Stock Forecast: Down 5.1% Today

AMC Entertainment Holdings Inc. Class A ($AMC) Stock Forecast: Down 5.2% Today

Zebra Technologies Corporation ($ZBRA) Stock Forecast: Down 5.1% Today

Trimble Inc. ($TRMB) Stock Forecast: Down 5.1% Today

Booking Holdings Inc. ($BKNG) Stock Forecast: Down 5.0% Today

Zoetis Inc. Class A ($ZTS) Stock Forecast: Down 5.3% Today

Amplitude Inc. ($AMPL) Stock Forecast: Down 5.1% Today

Excelerate Energy ($EE) Stock Forecast: Up 5.1% Today

Perrigo Company plc Price History

31.02.2026 - PRGO Stock was up 6.4%

• Despite a decrease in the price target by 11.61%, Perrigo's stock had a strong bullish movement, outperforming competitors on a challenging trading day.
• The stock's resilience and positive performance could be attributed to investors seeing potential value in the company beyond the revised price target.
• The internal realignment by Vanguard, resulting in 0 reported shares at the parent level, may have caused some uncertainty in the market but did not deter the bullish momentum of Perrigo's stock.
• Perrigo's ability to maintain an upward trajectory in the face of mixed analyst recommendations and market conditions showcases investor confidence in the company's long-term prospects.

03.02.2026 - PRGO Stock was down 8.5%

• Perrigo Company plc (PRGO) received a consensus "Hold" rating from analysts, with a lower-than-expected 12-month price target.
• Despite increased stakes from major investors like Bahl & Gaynor Inc. and Vanguard Group Inc., Perrigo missed Q4 EPS estimates and issued weaker FY2026 guidance, citing challenges in the infant formula segment.
• The company discussed its Q4 earnings, acknowledging temporary headwinds such as a soft cough and cold season and plant underabsorption, leading to a transition year in 2026.
• Analysts, including Jefferies, maintained a "Hold" rating on PRGO, signaling a cautious approach and a wait-and-see attitude towards operational improvements.

30.03.2026 - PRGO Stock was up 5.0%

• Perrigo Company plc declared a quarterly dividend of $0.29 per share, continuing its streak of dividend increases for 23 years. This likely increased investor confidence in the company's financial resilience and long-term growth potential.
• Despite a recent earnings shortfall, analysts predict Perrigo will maintain dividend coverage with future earnings, showing strength in overcoming short-term obstacles.
• An upgrade in Perrigo's stock rating from a "strong sell" to a "hold" by Zacks Research, along with revised EPS estimates, indicates a positive outlook for the company. This could have led to the stock price's upward momentum.
• The announcement of the dividend, enhanced analyst rating, and strategic focus on consumer health solutions are probable catalysts for Perrigo's positive performance in the market today.

20.02.2026 - PRGO Stock was down 5.1%

• Perrigo lagged behind its competitors and major market indices such as the S&P 500 and Dow Jones Industrial Average, causing a bearish shift in its stock.
• The decrease in ownership share by Ion Asset Management Ltd. potentially exerted downward pressure on the stock, indicating a lack of faith in Perrigo's future outlook.
• Despite positive company updates regarding advancements in its "Three-S" strategy and growth in core business shares, external factors and market sentiment appeared to overshadow these successes, leading to the stock's decline.
• A revision in the price target by Canaccord analyst Susan Anderson, despite acknowledging growth in Perrigo's primary operations, may have also impacted investor confidence and contributed to the downward momentum.

26.01.2026 - PRGO Stock was down 1.1%

• The bearish movement in Perrigo's stock price today could be attributed to the cautious outlook from analysts regarding the upcoming Q4 earnings, which is expected to show a decline in both EPS and revenue.
• The planned divestiture of Perrigo's rare disease affiliate for $294 million could be seen as a strategic move to focus on its core consumer goods business, but investors might be concerned about the impact on future revenue streams.
• Despite the positive news of a quarterly dividend announcement, the overall sentiment seems to be overshadowed by the upcoming earnings report and the company's recent performance, leading to the bearish market movement today.

06.04.2026 - PRGO Stock was up 7.6%

• Perrigo Company reported Q1 2026 financial results, with adjusted earnings of $0.43 per share, surpassing expectations. This positive earnings surprise likely contributed to the bullish movement in PRGO stock.
• Despite a 7.2% decrease in revenue year-over-year, the company's adjusted EPS exceeding estimates and the optimistic FY 2026 earnings guidance of $2.00 to $2.30 per share and revenues between $4.0 billion and $4.2 billion provided a strong outlook for investors.
• The announcement of a quarterly dividend of $0.29 per share, with an annualized yield of 10.0%, could have also attracted investors seeking income opportunities, further boosting PRGO's stock performance.
• Overall, the combination of better-than-expected earnings, positive future guidance, and the dividend announcement likely fueled investor confidence in Perrigo Company, leading to the bullish market movement.

06.04.2026 - PRGO Stock was up 5.4%

• Perrigo's positive market movement is linked to strong shareholder backing and confidence in the company's governance and financial adaptability. This is evident from the re-election of directors, approval of executive pay, and endorsement of the 2026 equity plan.
• Approval of the new 2026 Long-Term Incentive Plan and other proposals by shareholders points towards an optimistic view on the company's future growth and strategic endeavors.
• Despite projections of a decline in EPS and revenue for Q1 2026, investors are hopeful about Perrigo's cost-saving measures and restructuring attempts to generate long-term value.
• The ongoing investigation regarding potential misconduct by company officials may have caused initial concerns, but positive shareholder sentiment and strategic choices appear to have overshadowed these uncertainties, steering Perrigo's favorable market performance today.

17.02.2026 - PRGO Stock was up 7.8%

• Despite adjustments to PRGO's price target by an analyst, the company revealed increased share gains in its key sectors during Q4 2025, demonstrating strength and room for growth.
• Even though two investment firms reduced their stakes in PRGO, the rise in positions by other hedge funds signals confidence in the company's future performance.
• PRGO's decision to sell its Dermacosmetics business could be viewed as a strategic maneuver to enhance operational efficiency and concentrate on its core competencies, which could positively impact investor confidence.
• Conversations about PRGO's stock performance post-earnings report reflect market fluctuations and raise the possibility of a buying opportunity as investors evaluate the potential for a stock price rebound.

12.02.2026 - PRGO Stock was down 5.0%

• The increased stake by institutional investors like Dimensional Fund Advisors LP and BW Gestao de Investimentos Ltda. could indicate confidence in Perrigo's long-term prospects, yet the market reacted negatively.
• Despite the company's declaration of a quarterly dividend and analysts' "Hold" rating with a price target of $19.33, investors might be concerned about other factors impacting the stock.
• The bearish movement could be attributed to broader market conditions, sector-specific challenges, or specific company developments not shared widely.
• Investors may be reacting to potential risks or uncertainties surrounding Perrigo, leading to the downward pressure on the stock price despite the positive institutional investment activities.

27.01.2026 - PRGO Stock was down 2.5%

• PRGO stock experienced a significant bearish movement today, dropping by 6.7% in pre-market trading.
• The bearish trend can be attributed to the Q4 2025 earnings report where both adjusted EPS and revenue missed analyst estimates, leading to investor disappointment.
• Despite management highlighting strategic progress and market share gains, investors focused on the immediate financial shortfall, causing the stock price to decline.
• The upcoming ex-dividend date and historical dividend charts may have influenced some investors to sell off their positions, contributing to the downward pressure on PRGO stock.

13.03.2026 - PRGO Stock was up 5.1%

• Perrigo Co. PLC's stock displayed strong bullish momentum, outperforming competitors and major indices.
• The disclosure of a passive stake by Dimensional Fund Advisors may have boosted investor confidence, as indicated by the positive sentiment surrounding the stock.
• Speculation about a potential takeover by activist investor Starboard Value resulted in a significant increase in Perrigo's stock price, reflecting optimistic market outlook.
• Despite a slight underperformance on Thursday, the overall bullish trend in the stock can be attributed to takeover rumors and favorable market sentiment, leading to a noteworthy price surge.

11.04.2026 - PRGO Stock was down 5.0%

• Perrigo Company plc (PRGO) experienced a strong bearish movement today, closing down 4.40% at $11.72.
• Despite beating earnings estimates with an adjusted EPS of $0.43 per share in Q1, Perrigo's revenue of $969.2 million fell short of expectations, contributing to the stock's decline.
• The challenging market conditions, retailer inventory destocking, and revenue miss likely weighed on investor sentiment, leading to the bearish movement in the stock.
• Vanguard Group Inc.'s increased stake in the company may indicate long-term confidence, but short-term market factors and revenue concerns seem to have driven the stock price down today.